Miwa Higashi¹, Michi Okita¹, Takashi Ishii¹, Hanako Aoki¹, Takao Shoji², Yoshiyuki Onishi², Tetsuya Nagata¹, Makoto Koizumi², Kinya Ishikawa³, Takanori Yokota¹ (1.Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan, 2.Modality Research Laboratories, Daiichi Sankyo Co., Ltd., Japan, 3.Center for Personalized Medicine for Healthy Aging, Medical School Hospital, Tokyo Medical and Dental University, Japan)

Takayuki Kuroda¹, Kotaro Yoshioka¹, Su Lei Mon Su¹, Kumiko Sato¹, Eriko Isogai¹, Maho Katsuyama¹, Kie Yoshida-tanaka¹, Rintaro Iwata-Hara¹, Takao Yamaguchi², Tetsuya Nagata¹, Satoshi Obika², Takanori Yokota¹ (1.Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan, 2.Bioorganic Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Japan)

Kotaro Yoshioka^1,2, Mon Su Su Lei^1,2, Maho Katsuyama¹, Takayuki Kuroda¹, Kumiko Sato¹, Kie Tanaka¹, Eriko Isogai¹, Rintaro Iwata-Hara^1,2, Tetsuya Nagata^1,2, Takanori Yokota^1,2 (1.Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Japan, 2.NucleoTIDE and PepTIDE Drug Discovery Center, Tokyo Medical and Dental University, Japan)

Hideaki Nishihara¹, Kinya Matsuo¹, Satoru Morimoto², Hideyuki Okano² (1.Department of Neurology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan, 2.Department of Physiology, Keio University School of Medicine, Tokyo, Japan, Japan)

Hiroshi Fushiki, Tetsuro Kato, Masashi Maeda, Shigeo Matsui, Hitoshi Fumiyama, Tomoyuki Saito, Masanori Kobayashi, Soichiro Nakahara (Astellas Pharma Inc., Japan)

Masahiro Hatakeyama¹, Yutaka Otsu¹, Natsuki Akiyama¹, Takeshi Kanayama¹, Itaru Ninomiya¹, Osamu Onodera¹, Takayoshi Shimohata², Masato Kanazawa¹ (1.Department of Neurology, Brain Research Institute, Niigata University, Japan, 2.Department of Neurology, Gifu University Graduate School of Medicine, Japan)